
Infected blood - from scandal to inquiry
Start the Week
The Risks of Factor-Rate and Commercial Influence
This chapter delves into the risks associated with using factor-rate as a treatment despite safer alternatives being available and the potential commercial factors influencing its use. It discusses evidence of rebates for purchasing factor-rate, explores prevention measures for hepatitis and HIV in blood products, and highlights the financial aspect of heat-treating plasma. The chapter also touches upon the motivations behind becoming a medical researcher and the role of grief and anger in driving this decision.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.